INBX

Inhibrx Biosciences, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 2007919) · 2 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

Several filing signals but no multi-filing setup yet; see the timeline.

Radar 33 (low attention) · dilution pressure elevated · listing risk low · governance risk low · runway 11.6 mo · strongest signal: Negative equity (Jun 30, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

33Radar · attention score (0–100)

44Dilution pressure · financing + balance sheet

0Listing risk · exchange standards

0Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on INBX

Alerts

One email the morning INBX files anything that matches your rules (types, minimum score, setups).

12-month history

Every signal and setup for INBX back a year, not just 30 days — see how the current setup built.

Full analyst notes

What we noticed, evidence with links, what could prove us wrong, red-team caveats.

Full screener + CSV

All 985 flagged companies, same-day, sortable and exportable.

Get Pro · $18.85/mo founding rate See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$133.3Mcash + short-term investments as of Jun 30, 2026

11.6 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])

$-53.0Mstockholders' equity as of Jun 30, 2026

$174.6Mpublic float (10-K cover)

14.7Mshares outstanding as of Aug 7, 2026 · was 14.7M May 8, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

Date	Signal	Evidence	Score
Jun 30, 2026	▼ Negative equity	Stockholders' equity $-52,977,000 as of 2026-06-30 filing	31
Jun 30, 2026	▼ Runway 6–12 months	~11.6 months runway: liquidity $133,344,000 as of 2026-06-30, burn $137,773,306/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing	22

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans